Interview with Christian Frisch (Bio-Rad Laboratories) on anti-idiotypic antibodies for PK assays and HuCAL® technology

We sat down with Christian Frisch, R&D Manager at Bio-Rad Laboratories, at the 8th EBF Open Meeting to find out more about the work behind his poster on anti-idiotypic antibodies for PK assays and the HuCAL® recombinant antibody technology. We also asked Christian whether he believes the number of antibody based therapeutics will continue to increase.

Click here to view Bio-Rad’s company profile.